SURVEILLANCE STUDY OF PHOTOCONTACT DERMATITIS LEADING TO HOSPITALIZATION IN EUROPE WITH A SPECIAL FOCUS ON TOPICAL KETOPROFEN AND OTHER TOPICAL NSAIDs, INCLUDING EVALUATION OF SEVERE PHOTOSENSITIVITY REACTIONS (KETO1)

First published 29/06/2012

Last updated 23/04/2024

EU PAS number:

EUPAS2679

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Ketoprofen_-_Pilot_phase_Protocol_F.1_11-06-2012[1]

English (333.67 KB - PDF) View document

Study results

Study report

Other information

Study, other information

Keto1_vers F1 Questionnaire 11-06-2012

English (457.2 KB - PDF) View document

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Composition of steering group and observers

Composition of the Steering Committee

English (108.05 KB - PDF) View document

SURVEILLANCE STUDY OF PHOTOCONTACT DERMATITIS LEADING TO HOSPITALIZATION IN EUROPE WITH A SPECIAL FOCUS ON TOPICAL KETOPROFEN AND OTHER TOPICAL NSAIDs, INCLUDING EVALUATION OF SEVERE PHOTOSENSITIVITY REACTIONS (KETO1)

Secondary tabs

Share this page